Drawing for GENECHRON

USPTO serial 79245185

GENECHRON

Reviewed by CopyMark Law Group

Reg. 5980142Status 709
Filing date
Status date
Registration date
Feb 11, 2020
Examiner
BUONGIORNO, CHRISTOPHER L
Law office
TMEG LAW OFFICE 101

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENECHRON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

Lawrence E. Abelman Abelman Frayne & Schwab666 3rd Avenue10th FloorNew York, NY 10017

Goods and services

ClassDescriptionStatusFirst use
005Reagents for use in medical genetic testing; diagnostic biomarker reagents for medical purposesSECTION 71 - CANCELLED—
042Scientific research in the field of genetics; scientific analysis in the field of genetics; scientific research advisory services in the field of gene therapy; information on the subject of scientific research in the fields of biochemistry and biotechnology; testing of biotechnology products; evaluation of chemical analyses; conducting clinical research and trials for others; analysis in the field of molecular biology; structural and functional analysis of genomes; scientific research for medical purposes in the area of cancerous diseases; research and development of products in the field of biotechnologySECTION 71 - CANCELLED—
044Medical diagnostic services; genetic testing for medical purposes; laboratory analysis services in the fields of bacteriology, chemistry, biochemistry, biotechnology, cosmetics for the purpose of treating persons; medical analysis services for the diagnosis of cancer; medical testing of blood; RNA and DNA analysis for cancer diagnosis and prognosis; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; genetic testing of animals for medical diagnostic or treatment purposes; medical services in the field of oncology; medical analysis services for cancer diagnosis and prognosis; genetic counseling; medical and health assessment services relating to DNA, genetics and genetic testing; medical screeningSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2026C71TCANCELLED SECTION 71—
Feb 11, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 19, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 3, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 3, 2020FIMPFINAL DISPOSITION PROCESSED—
May 11, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2019ALIEASSIGNED TO LIE—
Oct 15, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 15, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 15, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 15, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 18, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 18, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 18, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 17, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2019RFNTREFUSAL PROCESSED BY IB—
Dec 29, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 29, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2018DOCKASSIGNED TO EXAMINER—
Nov 23, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance